Skip to content

Clinical trials

Expanded access Waldenstrom Macroglobulinemia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Waldenstrom Macroglobulinemia Phase: Expanded access Clear all

3 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
No longer available2
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Barbara Ann Karmanos Cancer Institute1
BeiGene1
Loxo Oncology, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Waldenstrom Macroglobulinemia3
Leukemia, Lymphocytic, Chronic, B-Cell2
Lymphoma, Mantle-Cell2
Recurrence2
Blast Crisis1
Burkitt Lymphoma1
Congenital Abnormalities1
Dendritic Cell Sarcoma, Interdigitating1
Hematologic Diseases1
Hodgkin Disease1

Trials

Showing 76 to 3 of 3. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.